Design, synthesis and evaluation of 2, 6, 8-substituted Imidazopyridine derivatives as potent PI3Kα inhibitors
Inhibition of PI3K pathway has become a desirable strategy for cancer treatment. In this work, a series of 2, 6, 8-substituted Imidazo[1,2-a]pyridine derivatives were designed and screened for their activities against PI3Kα and a panel of PI3Kα-addicted cancer cells. Among them, compound 35 was iden...
Saved in:
Main Authors: | Rui Chen (Author), Zhongyuan Wang (Author), Lijie Sima (Author), Hu Cheng (Author), Bilan Luo (Author), Jianta Wang (Author), Bing Guo (Author), Shunyi Mao (Author), Zhixu Zhou (Author), Jingang Peng (Author), Lei Tang (Author), Xinfu Liu (Author), Weike Liao (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer
by: Lijie Sima, et al.
Published: (2024) -
Identification of novel PD-1/PD-L1 small molecule inhibitors: virtual screening, synthesis and in vitro characterisation
by: Tingting Wu, et al.
Published: (2024) -
Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1
by: Jung-Chen Su, et al.
Published: (2018) -
Synthesis and biological activity of 2-cyanoacrylamide derivatives tethered to imidazopyridine as TAK1 inhibitors
by: Seok Jong Kang, et al.
Published: (2020) -
Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity
by: Paul Le Baccon-Sollier, et al.
Published: (2020)